Company intelligence / Profile preview

苏州康尔生物医药

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Suzhou Kanger Biological Medicine is a biotechnology company based in Suzhou, China, focused on the discovery and development of innovative small molecule therapeutics. The company primarily targets G protein-coupled receptors (GPCRs) and ion channels to address unmet medical needs in pain management, inflammation, and neurological disorders. Leveraging its internal R&D capabilities, Kanger Bio aims to advance a pipeline of novel drug candidates from early-stage discovery through clinical development. The company is situated within the Suzhou Industrial Park, a major hub for life sciences innovation in China.

Therapeutic areas: NeurologyImmunology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on 苏州康尔生物医药.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 苏州康尔生物医药.

Explore the full profile